SPYI’s Yield Surprise: Capital Return Dominates Income
SPYI is delivering a near-12% yield year-to-date, but most distributions are classified as return of capital, which c...
Timing matters: automatic rebalancing should occur as your allocations drift beyond set thresholds.
18,157 articlesSPYI is delivering a near-12% yield year-to-date, but most distributions are classified as return of capital, which c...
A notable insider maneuver at CareDx drew attention to the stock. This article breaks down the sale, what it means fo...
AMD’s surprise move to buy MEXT promises AI-driven memory optimization that could trim data center costs. Learn what ...
Nike stock has fallen significantly from its 52-week peak, even as the CEO buys shares. This guide explains what the ...
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Two substantial share sales by Klaviyo's co-CEO in February and March sparked questions about whether this is a warni...
Biotech stocks can swing on earnings surprises. This article explains why lenz therapeutics stock crashed, what it me...
A big data-center lease helped Applied Digital stock soar, signaling strong demand for AI infrastructure. Learn what ...
A sudden drop in Navitas stock sent ripples through growth-focused portfolios. This guide explains the key drivers, w...
On a midweek Tuesday when tech stocks sagged, Salesforce bucked the trend. A fresh bullish note from a respected anal...
A large insider sale at Relay Therapeutics coincides with a dramatic stock rally. This article breaks down what the r...
Karooooo stock jumped today after a solid earnings report that topped expectations. This article breaks down the numb...